The AMPK agonist 5-Aminoimidazole-4-carboxamide ribonucleotide (AICAR) can salvage glycolytic reprogramming and inflammasome activation in macrophages expressing mutant FLT4 to prevent recurrent infections [73]. The gene discussed is FLT4; the disease is infection.